MNMelanie NicolPharmD, PhDVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024Controversies and Consistencies Whether Men and Women Respond Differently to PrEP | Melanie NicolView Video
HHQHarry H. QinMD, PhDVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024Ainuovirine - A New-Generation Non-nucleoside Reverse Transcriptase Inhibitor | Harry H. QinView Video
KDKeith DunnPharmD, BCPS, AAHIVESlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024Gilead Sciences: HIV Drug Development Pipeline | Keith DunnView Slideset
KDKeith DunnPharmD, BCPS, AAHIVEVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024Gilead Sciences: HIV Drug Development Pipeline | Keith DunnView Video
SPSimon PortsmouthMBChB, MD, FRCPVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024Development of Antiviral Drugs for COVID-19 in 2024: Endpoints and Unmet Needs | Simon PortsmouthView Video
PGPierre GiguèreBPharm, MScSlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024Case Presentation: Unmasking the Enemy: Enzalutamide-Induced HIV Treatment Failure | Pierre GiguèreView Slideset
PGPierre GiguèreBPharm, MScVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024Case Presentation: Unmasking the Enemy: Enzalutamide-Induced HIV Treatment Failure | Pierre GiguèreView Video
CMCatia MarzoliniPharmD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024Drug-Drug Interactions in Specific Populations | Catia MarzoliniView Slideset
CMCatia MarzoliniPharmD, PhDVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024Drug-Drug Interactions in Specific Populations | Catia MarzoliniView Video
TFTom FletcherPhD, FRCPVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024Viral Haemorrhage Fevers - Recent Advances in Therapeutic Trials | Tom FletcherView Video
KSKimberly StrublePharmDSlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024Regulatory Considerations for Emerging Infections | Kimberly StrubleView Slideset
KSKimberly StrublePharmDVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024Regulatory Considerations for Emerging Infections | Kimberly StrubleView Video
